7TM (Denmark) focuses on the discovery and development of peptides and small molecules for obesity, based on core expertise in seven transmembrane receptors and disease biology.
http://www.7tm.com
Avantium (Netherlands) provides product and process development services to the chemical and pharmaceutical sectors.
http://www.avantium.com
Onyvax, Inc. (UK) is developing allogeneic-cell based vaccines for the treatment of cancer. The company has programs in clinical development in prostate cancer.
http://www.onyvax.com
PharmaKodex (UK) is an emerging speciality pharmaceuticals company that is developing a range of improved medicinal products (IMPS) with a focus on neurology an and emphasis on treatments for the young and elderly where special delivery can provide significant benefits such as ease of medication for patients and care-givers, rapid action onset and improved treatment outcomes.
http://www.pharmakodex.com
Resistentia Pharmaceuticals AB (Sweden) develops and commercializes immunotherapies as second generation to monoclonal antibodies for the treatment of chronic inflammatory diseases, including asthma and allergy.
http://www.resistentia.se
Syntaxin Ltd. (UK) uses its substantial knowledge of microbial proteins and expertise in protein engineering to discover and develop novel biopharmaceuticals that block cell secretion in a variety of cell types for the treatment of pain, nervous, respiratory and metabolic diseases.
http://www.syntaxin.com